Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-01-06 @ 2:19 AM
Study NCT ID:
NCT04126460
Status:
UNKNOWN
Last Update Posted:
2019-10-15
First Post:
2019-10-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High-risk Recurrent or Second Primary HNSCC With PD-1 Antibody Adjuvant After Salvage Surgery(RePASS)
Sponsor:
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Organization: